Besides the altered iron metabolism and enhanced iron sequestration due to an increase in hepcidin expression, in cancer patients and granulomatous patients (CGD) that suffer from primary immunodeficiency, the release of inflammatory cytokines also reduces red blood cell survival, thereby reinforcing the progression of anemia. This evidence concerns the gene HAMP and anemia (phenotype).